• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

乳腺癌的乳腺钼靶筛查。我们发现了哪些癌症?

Mammographic screening for breast cancer. What cancers do we find?

作者信息

Nordén T, Thurfjell E, Hasselgren M, Lindgren A, Norgren A, Bergström R, Holmberg L

机构信息

Department of Surgery, University Hospital, Uppsala, Sweden.

出版信息

Eur J Cancer. 1997 Apr;33(4):624-8. doi: 10.1016/s0959-8049(96)00482-0.

DOI:10.1016/s0959-8049(96)00482-0
PMID:9274445
Abstract

The aim of this study was to compare lymph node involvement of breast cancer cases detected at mammography screening with clinically-detected cases. During a 3-year period, 273 primary breast cancers were detected in a population-based screening programme, and 149 primary breast cancers were diagnosed clinically. Lymph node involvement was evaluated in univariate and multivariate logistic regression models correcting for tumour size, histological grade, steroid receptor status and DNA-ploidy. Patients with screen-detected cancers had a low relative risk of having lymph node metastases (univariate, OR = 0.31; 95% confidence interval = 0.19-0.52). In the multivariate logistic regression model, the relative risk was halved (OR = 0.47; 0.28-0.78). The reduced risk was more pronounced for women younger than 50 years of age compared to older women. The risk for screen-detected cases of having lymph node metastases at diagnosis was statistically significantly lower than for clinically-detected cases. The marked reduction, even when correcting for tumour size, makes it less likely that factors such as detection of clinically innocent tumours, length bias sampling or clinical symptoms related to axillary metastases can explain the whole difference. The results indicate at least part of the effect may be explained by tumour progression in the late preclinical detectable phase.

摘要

本研究的目的是比较在乳腺钼靶筛查中检测出的乳腺癌病例与临床检测出的病例的淋巴结受累情况。在3年期间,在一项基于人群的筛查计划中检测出273例原发性乳腺癌,149例原发性乳腺癌经临床诊断。在单变量和多变量逻辑回归模型中评估淋巴结受累情况,对肿瘤大小、组织学分级、类固醇受体状态和DNA倍性进行校正。筛查发现癌症的患者发生淋巴结转移的相对风险较低(单变量,OR = 0.31;95%置信区间 = 0.19 - 0.52)。在多变量逻辑回归模型中,相对风险减半(OR = 0.47;0.28 - 0.78)。与老年女性相比,50岁以下女性风险降低更为明显。筛查发现的病例在诊断时发生淋巴结转移的风险在统计学上显著低于临床检测出的病例。即使校正肿瘤大小后仍有显著降低,这使得诸如检测到临床无害肿瘤、长度偏倚抽样或与腋窝转移相关的临床症状等因素不太可能解释全部差异。结果表明,至少部分效应可能由临床前可检测晚期的肿瘤进展来解释。

相似文献

1
Mammographic screening for breast cancer. What cancers do we find?乳腺癌的乳腺钼靶筛查。我们发现了哪些癌症?
Eur J Cancer. 1997 Apr;33(4):624-8. doi: 10.1016/s0959-8049(96)00482-0.
2
Age-specific effectiveness of the Nijmegen population-based breast cancer-screening program: assessment of early indicators of screening effectiveness.
J Natl Cancer Inst. 1994 Mar 16;86(6):436-41. doi: 10.1093/jnci/86.6.436.
3
Aggressiveness of breast cancers found with and without screening.筛查发现与未筛查发现的乳腺癌的侵袭性。
BMJ. 1992 Feb 22;304(6825):467-9. doi: 10.1136/bmj.304.6825.467.
4
Detection method, tumour size and node metastases in breast cancers diagnosed during a trial of breast cancer screening.在一项乳腺癌筛查试验期间诊断出的乳腺癌的检测方法、肿瘤大小和淋巴结转移情况。
Eur J Cancer Clin Oncol. 1987 Jul;23(7):959-62. doi: 10.1016/0277-5379(87)90341-5.
5
Using tumor phenotype, histological tumor distribution, and mammographic appearance to explain the survival differences between screen-detected and clinically detected breast cancers.利用肿瘤表型、组织学肿瘤分布和乳房X线摄影表现来解释筛查发现和临床发现的乳腺癌之间的生存差异。
APMIS. 2014 Aug;122(8):699-707. doi: 10.1111/apm.12294.
6
The comparative value of mammographic screening for women 40-49 years old versus women 50-64 years old.40至49岁女性与50至64岁女性进行乳腺钼靶筛查的比较价值。
AJR Am J Roentgenol. 1995 May;164(5):1099-103. doi: 10.2214/ajr.164.5.7717212.
7
Treatment of the axilla in patients with screen-detected breast cancer.筛查发现的乳腺癌患者腋窝的治疗
Br J Surg. 1993 Apr;80(4):436-8. doi: 10.1002/bjs.1800800409.
8
Risk of non-sentinel node metastases in patients with symptomatic cancers compared to screen-detected breast cancers.有症状癌症患者与筛查发现的乳腺癌患者相比,非前哨淋巴结转移的风险。
Acta Oncol. 2016;55(4):455-9. doi: 10.3109/0284186X.2015.1094186. Epub 2015 Oct 9.
9
Is the presence of mammographic comedo calcification really a prognostic factor for small screen-detected invasive breast cancers?乳腺钼靶检查发现的粉刺样钙化的存在真的是小的筛查发现的浸润性乳腺癌的一个预后因素吗?
Clin Radiol. 2003 Jan;58(1):54-62. doi: 10.1053/crad.2002.1110.
10
Axillary node dissection in patients with breast cancer diagnosed through the Ontario Breast Screening Program: a need for minimally invasive techniques.通过安大略省乳腺癌筛查计划确诊的乳腺癌患者的腋窝淋巴结清扫术:对微创技术的需求。
Can J Surg. 1997 Oct;40(5):377-82.

引用本文的文献

1
Short- and Long-Term (10-year) Results of an Organized, Population-Based Breast Cancer Screening Program: Comparative, Observational Study from Hungary.一项基于人群的有组织乳腺癌筛查项目的短期和长期(10年)结果:来自匈牙利的比较性观察研究。
World J Surg. 2018 May;42(5):1396-1402. doi: 10.1007/s00268-018-4486-0.
2
Temporal trends in geographic disparities in small-area breast cancer incidence and mortality, 1988 to 2005.1988 年至 2005 年小区域乳腺癌发病率和死亡率的地理差异的时间趋势。
Cancer Epidemiol Biomarkers Prev. 2010 Apr;19(4):1122-31. doi: 10.1158/1055-9965.EPI-09-0966. Epub 2010 Mar 30.
3
Screen-detected vs clinical breast cancer: the advantage in the relative risk of lymph node metastases decreases with increasing tumour size.
筛查发现的乳腺癌与临床诊断的乳腺癌:淋巴结转移相对风险的优势随肿瘤大小增加而降低。
Br J Cancer. 2005 Jan 17;92(1):156-61. doi: 10.1038/sj.bjc.6602289.
4
Screening Mammography Program of British Columbia: pattern of use and health care system costs.不列颠哥伦比亚省乳腺钼靶筛查项目:使用模式与医疗保健系统成本
CMAJ. 1999 Feb 9;160(3):337-41.